From neurofilament research to multiple sclerosis clinical practice Where do we stand?

被引：6
作者：
Bodini, Benedetta [1 ]
Calabresi, Peter Arthur [2 ]
机构：
[1] UPMC, Pitie Salpetriere Hosp, Sorbonne Univ,CNRS UMR 7225, Inst Cerveau & Moelle Epiniere,ICM,Inserm UMR S, Paris, France
[2] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD USA
来源：
NEUROLOGY | 2017年 / 88卷 / 09期
关键词：
BIOMARKERS; THERAPY;
D O I：
10.1212/WNL.0000000000003676
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：816 / 817
页数：2
相关论文
共 10 条
[1]   The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament levelNO [J].
Arrambide, Georgina ;
Espejo, Carmen ;
Tintore, Mar .
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (10) :1240-1242
[2]   Body fluid biomarkers in multiple sclerosis [J].
Comabella, Manuel ;
Montalban, Xavier .
LANCET NEUROLOGY, 2014, 13 (01) :113-126
[3]  
Correale J., 2016, BRAIN, paww258
[4]   Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS - Neurofilament as a Surrogate of Disease Progression [J].
Gnanapavan, Sharmilee ;
Grant, Donna ;
Morant, Steve ;
Furby, Julian ;
Hayton, Tom ;
Teunissen, Charlotte E. ;
Leoni, Valerio ;
Marta, Monica ;
Brenner, Robert ;
Palace, Jacqueline ;
Miller, David H. ;
Kapoor, Raj ;
Giovannoni, Gavin .
PLOS ONE, 2013, 8 (08)
[5]   Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis [J].
Kuhle, J. ;
Leppert, D. ;
Petzold, A. ;
Regeniter, A. ;
Schindler, C. ;
Mehling, M. ;
Anthony, D. C. ;
Kappos, L. ;
Lindberg, R. L. P. .
NEUROLOGY, 2011, 76 (14) :1206-1213
[6]   Serum neurofilament is associated with progression of brain atrophy and disability in early MS [J].
Kuhle, Jens ;
Nourbakhsh, Bardia ;
Grant, Donna ;
Morant, Steve ;
Barro, Christian ;
Yaldizli, Ozgur ;
Pelletier, Daniel ;
Giovannoni, Gavin ;
Waubant, Emmanuelle ;
Gnanapavan, Sharmilee .
NEUROLOGY, 2017, 88 (09) :826-831
[7]   Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS [J].
Malmeström, C ;
Haghighi, S ;
Rosengren, L ;
Andersen, O ;
Lycke, J .
NEUROLOGY, 2003, 61 (12) :1720-1725
[8]   The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES [J].
Salzer, Jonatan .
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (10) :1239-1240
[9]   Neurofilaments as biomarkers in multiple sclerosis [J].
Teunissen, Charlotte E. ;
Khalil, Michael .
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (05) :552-556
[10]   Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics [J].
Vidal-Jordana, Angela ;
Sastre-Garriga, Jaume ;
Perez-Miralles, Francisco ;
Pareto, Deborah ;
Rio, Jordi ;
Auger, Cristina ;
Tintore, Mar ;
Rovira, Alex ;
Montalban, Xavier .
JOURNAL OF NEUROIMAGING, 2016, 26 (05) :532-538
1